Clinical Trial Update: Study of ESG406 in Adults With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ESG406 in adults with locally advanced or metastatic solid tumors. The study is currently recruiting and sponsored by Shanghai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ESG406

Snippet

Sponsor: Shanghai Escugen Biotechnology Co., Ltd | Conditions: Locally Advanced/Metastatic Solid Tumors | Phase 1 | Status: RECRUITING